Antibodies that immunospecifically bind BLyS
AssigneeHuman Genome Sciences, Inc.
InventorsSteven M. Ruben, Gil H. Choi, Tristan Vaughan, David Hilbert
Life of this patent
Estimating the term…
Loading patent…
AssigneeHuman Genome Sciences, Inc.
InventorsSteven M. Ruben, Gil H. Choi, Tristan Vaughan, David Hilbert
Estimating the term…
The present invention relates to antibodies and related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention also relates to methods and compositions for detecting or diagnosing a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate function of B Lymphocyte Stimulator comprising antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator. The present invention further relates to methods and compositions for preventing, treating or ameliorating a disease or disorder associated with aberrant B Lymphocyte Stimulator expression or inappropriate B Lymphocyte Stimulator function comprising administering to an animal an effective amount of one or more antibodies or fragments or variants thereof or related molecules that immunospecifically bind to B Lymphocyte Stimulator.
An isolated antibody that immunospecifically binds B Lymphocyte Stimulator protein wherein said antibody comprises a first amino acid sequence at least 85% identical to amino acid residues 1–123 of SEQ ID NO:327 and a second amino acid sequence at least 85% identical to amino acid residues 141–249 of SEQ ID NO:327 and wherein said B Lymphocyte Stimulator protein is selected from the group consisting of:
An isolated antibody that immunospecifically binds B Lymphocyte Stimulator protein wherein said antibody comprises amino acid residues 1–123 of SEQ ID NO:
An antibody purified from the cell line contained in American Type Culture Collection Deposit Number PTA-3239.
An antibody purified from the cell line contained in American Type Culture Collection Deposit Number PTA-3240.
An isolated antibody that immunospecifically binds B Lymphocyte Stimulator protein wherein said antibody comprises amino acid residues 1–123 of SEQ ID NO:2 and amino acid residues 141–249 of SEQ ID NO:2 and wherein said B Lymphocyte Stimulator protein is selected from the group consisting of:
Dependencies are inferred from the claim text.